Value proposition

Kane is actively advancing technologies and products that break up biofilms and destroy bacteria.

With 81 patents and patents pending, Kane Biotech is Kane Biotech is THE Biofilm Company. Creating smarter ways to fight bacteria, Kane is leading the advancement of technologies and products that break up biofilms and destroy bacteria.

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.


StrixNBTM, DispersinB®, AledexTM, bluestemTM, bluestem®, silkstemTM, goldstemTM, coactiv+TM, coactiv+®, DermaKBTM and DermaKB BiofilmTM are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE" and on the OTCQB Venture Market under the symbol “KNBIF”.

Animal Health, Bacterial Biofilm Dispersion, Human Health, Innovation, and Global Partnership